Collaboration between Uczelnia Biznesu i Nauk Stosowanych „Varsovia” and Polpharma S.A. – the largest pharmaceutical company in Poland.
On 23 February in Warsaw, HM prof. dr hab. Paweł Czarnecki, MBA, DBA, LL.M, dr h.c. Provost of Uczelnia Biznesu i Nauk Stosowanych „Varsovia” and Mr Sebastian Szymanek, MSc farm, President of the Management Board of Zakłady Farmaceutyczne Polpharma S.A. signed a cooperation agreement.
Zakłady Farmaceutyczne Polpharma S.A. took a substantive patronage over postgraduate studies taught at Uczelnia Biznesu i Nauk Stosowanych „Varsovia”: MBA-Clinical Research, MBA-Healthcare Management, MPH-Public Health, DBA-Clinical Research, DBA-Healthcare Management, DPH-Doctor of Public Health.
The agreement also covers possible joint activities in the field of education and research, and it opens a new way for the implementation of apprenticeships by students of Uczelnia Biznesu i Nauk Stosowanych „Varsovia” in the entities of the Polpharma S.A. Group.
Polpharma S.A. is the largest pharmaceutical company in Poland. It has been present on the market for 85 years, producing nearly 780 different drugs and pharmaceutical products – all in 8 production plants in Poland and abroad. We are proud that Polpharma S.A. has joined substantive partners of our MBA, DBA, DPH and MPH postgraduate programmes. Other notable patrons include the Supreme Pharmaceutical Chamber, the Polish Federation of Hospitals, National Drug Manufacturers and the Association for Good Clinical Research Practice in Poland.
